Manijeh Daneshmand

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

Ming‐Sound Tsao, Akira Sakurada, Jean-Claude Cutz et al. · New England Journal of Medicine · 2005 · 1.9K citations

Medicine, Oncology, Pharmacology +14

Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

Jeong Heo, Tony Reid, Leyo Ruo et al. · Nature Medicine · 2013 · 776 citations · Full text

Medicine, Immunology, Oncology +16

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

Caroline J. Breitbach, James M. Burke, Derek J. Jonker et al. · Nature · 2011 · 550 citations

Pharmacy, Oncology, Pharmaceutics +12

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial

Byeong-Ho Park, Tae-Ho Hwang, Ta‐Chiang Liu et al. · The Lancet Oncology · 2008 · 522 citations

Medicine, Oncology, Pharmacotherapy +15

Targeted Inflammation During Oncolytic Virus Therapy Severely Compromises Tumor Blood Flow

Caroline J. Breitbach, Jennifer M Paterson, Chantal G. Lemay et al. · Molecular Therapy · 2007 · 277 citations · Full text

Medicine, Cancer Biology, Oncology +17